viernes, 9 de marzo de 2018

National Nutrition Month® (see related guidelines) 7 | National Guideline Clearinghouse

Search | National Guideline Clearinghouse

ngc

  • GUIDELINE SUMMARY
    •  
  • NGC:010402
    •  
  • 1994 JUN (REVISED 2014 AUG)

Guidelines for the diagnosis and treatment of cobalamin and folate disorders.

British Society for Haematology Guidelines
  • GUIDELINE SUMMARY
    •  
  • NGC:010501
    •  
  • 2006 JAN (REVISED 2014 JUL)

Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease.

National Guideline Centre
  • GUIDELINE SUMMARY
    •  
  • NGC:010640
    •  
  • 1999 (REVISED 2015 FEB 17)

Recommendations for prevention of weight gain and use of behavioural and pharmacological interventions to manage overweight and obesity in adults in primary care.

Canadian Task Force on Preventive Health Care
  • GUIDELINE SUMMARY
    •  
  • NGC:010590
    •  
  • 2012 JUL (REVISED 2014 OCT)

The Clinical Pharmacogenetics Implementation Consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.

Clinical Pharmacogenetics Implementation Consortium
  • GUIDELINE SUMMARY
    •  
  • NGC:010572
    •  
  • 2006 MAY (REVISED 2014)

Adult weight management evidence-based nutrition practice guideline.

Academy of Nutrition and Dietetics
  • GUIDELINE SUMMARY
    •  
  • NGC:011053
    •  
  • 2016 JAN

IWGDF guidance on footwear and offloading interventions to prevent and heal foot ulcers in patients with diabetes.

International Working Group on the Diabetic Foot

Cirrhosis in over 16s: assessment and management.

National Guideline Centre
  • GUIDELINE SUMMARY
    •  
  • NGC:009796
    •  
  • 1998 JAN (REVISED 2013 FEB)

Management of adult patients with ascites due to cirrhosis: update 2012.

American Association for the Study of Liver Diseases
  • GUIDELINE SUMMARY
    •  
  • NGC:009371
    •  
  • 1996 (REVISED 2013 JAN 1)

Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement.

U.S. Preventive Services Task Force
  • GUIDELINE SUMMARY
    •  
  • NGC:009979
    •  
  • 2013 JUL

Obesity prevention and management.

University of Michigan Health System
  • GUIDELINE SUMMARY
    •  
  • NGC:010790
    •  
  • 2011 MAR (REVISED 2015 AUG 26)

Diabetic foot problems: prevention and management.

National Institute for Health and Care Excellence (NICE)
  • GUIDELINE SUMMARY
    •  
  • NGC:008274
    •  
  • 2011 JAN 18 (REAFFIRMED 2016 NOV 22)

Evidence-based guideline update: plasmapheresis in neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

American Academy of Neurology
  • GUIDELINE SUMMARY
    •  
  • NGC:010924
    •  
  • 2016 FEB 24

Ezetimibe for treating primary heterozygous-familial and non-familial hypercholesterolaemia.

National Institute for Health and Care Excellence (NICE)
  • GUIDELINE SUMMARY
    •  
  • NGC:009639
    •  
  • 2013 MAR

Guidelines for the diagnosis and management of gastroesophageal reflux disease.

American College of Gastroenterology
Related Guideline Synthesis: Diagnosis and Treatment of Gastroesophageal Reflux Disease (GERD)

Guideline for positioning the patient.

Association of periOperative Registered Nurses
  • GUIDELINE SUMMARY
    •  
  • NGC:009591
    •  
  • 2013 FEB

Management of newly diagnosed type 2 diabetes mellitus (T2DM) in children and adolescents.

American Academy of Pediatrics
  • GUIDELINE SUMMARY
    •  
  • NGC:010274
    •  
  • 1994 (REVISED 2013 SEP)

SOLUTIONS® wound care algorithm.

ConvaTec
  • GUIDELINE SUMMARY
    •  
  • NGC:010781
    •  
  • 2004 (UPDATED 2015 AUG 26)

Type 1 diabetes in adults: diagnosis and management.

National Guideline Centre
  • GUIDELINE SUMMARY
    •  
  • NGC:010195
    •  
  • 2013 DEC

Intravenous fluid therapy in adults in hospital.

National Guideline Centre
  • GUIDELINE SUMMARY
    •  
  • NGC:009588
    •  
  • 2013 FEB (REAFFIRMED 2015)

Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing.

Clinical Pharmacogenetics Implementation Consortium


Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)